Australia's Nova Eye Medical jumps to 8-month high on NMPA approval

Nova Eye Medical

30/09/2025 02:24

** Shares of Australia's Nova Eye Medical EYE.AX rise as much as 16.6% to A$0.170; their highest since January 28

** Ophthalmic treatment technologies firm says China's NMPA approved the registration of iTrack Advance, a glaucoma surgical device, in the Asian country

** Nearly 1.2 million shares change hands, around 4.1x 30-day average; co's busiest day since August 19

** Including session's moves, EYE up 6.3% YTD

(Reporting by Keshav Singh Chundawat in Bengaluru)

((Keshav.singhchundawat@thomsonreuters.com))